Search
for
Sort by
Research 31–60 of 1000+
- ПОДРЫВАЮЩИЙ ФОЛЛИКУЛИТ ГОФФМАНА. ПРИНЦИПЫ ДИАГНОСТИКИ И ЛЕЧЕНИЯ: ОБЗОР ЛИТЕРАТУРЫ
- Chemotherapy-Induced Alopecia Beyond Cytotoxicity: Hair Follicle Immune Privilege Collapse and JAK-STAT Signaling
- Overlapping features of atopic dermatitis and alopecia areata: from pathogenesis to treatment
- Ruxolitinib reverses alopecia areata via a triple mechanism: JAK-STAT inhibition, localized oxidative stress attenuation and selective apoptosis modulation
- Multimodal roles of transient receptor potential channel activation in inducing pathological tissue scarification
- Nocturnal eczema: Review of sleep and circadian rhythms in children with atopic dermatitis and future research directions
- Pathobiology questions raised by telogen effluvium and trichodynia in COVID‐19 patients
- Pathophysiology of Alopecia Areata in the Pediatric Patient
- THE GLOBAL CHALLENGE OF CHEMOTHERAPY TOXICITY: RETHINKING SUPPORTIVE CARE IN MODERN ONCOLOGY
- Genetically engineered biomimetic ATP-responsive nanozyme for the treatment of cardiac fibrosis
- DISRUPTION OF HAIR FOLLICLE IMMUNE PRIVILEGE IN ALOPECIA AREATA: ENIGMATIC MECHANISMS AND EMERGING CONCEPTS
- Biological therapy in the treatment of melanoma
- Nanomedicine-based immunotherapy for tissue regeneration
- Evidence on Hidradenitis Suppurativa as an Autoinflammatory Skin Disease
- Editorial: Crosstalk: skin cells and immune cells in inflammatory skin diseases
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Signaling pathways and targeted therapeutic strategies for polycystic ovary syndrome
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Editorial: Targeted immunological therapies in dermatology
- Cytokine-Targeting Biologic Therapies for Alopecia Areata: A Comprehensive Review of Mechanism of Action, Clinical Efficacy, and Adverse Events
- Alopecia areata: from immunopathogenesis to emerging therapeutic approaches
- Newly Developed Targeted Therapies Against the Androgen Receptor in Triple-Negative Breast Cancer: A Review
- Biologics and Small Molecule Targeted Therapies for Pediatric Alopecia Areata, Psoriasis, Atopic Dermatitis, and Hidradenitis Suppurativa in the US: A Narrative Review
- Toll-like receptor-targeted anti-tumor therapies: Advances and challenges
- Functional enhancement strategies for immunomodulation of mesenchymal stem cells and their therapeutic application
- Targeted delivery of extracellular vesicles: the mechanisms, techniques and therapeutic applications
- Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Dermatologic adverse events in pediatric patients receiving targeted anticancer therapies: A pooled analysis